Citation Impact
Citing Papers
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019
2020 Standout
Systematic overview of economic evaluations of health-related rehabilitation
2015
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Verification problems in diagnostic accuracy studies: consequences and solutions
2011
Thiazolidinediones
2004 Standout
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol
2005
Adverse Health Effects of Marijuana Use
2014 Standout
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
2020
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
2007
Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus
2004
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
The metabolic syndrome
2010 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
2017
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study
2011
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
2012
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Colorectal cancer
2013 Standout
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
2003
Use of health resources and healthcare costs associated with frailty: The FRADEA study
2016
Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies
2011
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
Performance of screening tests for child physical abuse in accident and emergency departments
2008
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Burden and consequences of child maltreatment in high-income countries
2008 Standout
Colorectal cancer
2019 Standout
Global cancer statistics
2011 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The metabolic syndrome
2005 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
2011 Standout
Non-alcoholic fatty liver disease
2021 Standout
Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
2010
Graves' Ophthalmopathy
2010 Standout
Midwifery and quality care: findings from a new evidence-informed framework for maternal and newborn care
2014 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition
2015
Cost-effectiveness of Colorectal Cancer Screening
2011
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
Systemic treatment of hepatocellular carcinoma: An EASL position paper
2021
Frailty: implications for clinical practice and public health
2019 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
American Cancer Society guidelines on nutrition and physical activity for cancer prevention
2012
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Progress with thiazolidinediones in the management of type 2 diabetes mellitus
2004
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial
2010
C‐reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin‐sensitizing treatment with thiazolidinediones
2004
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
2009 StandoutNobel
Anti-D administration in pregnancy for preventing Rhesus alloimmunisation
2013
The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence
2010
Peroxisome Proliferator-Activated Receptor-γ in Thyroid Eye Disease: Contraindication for Thiazolidinedione Use?
2003
Hepatocellular carcinoma
2022 Standout
Conscious Sedation versus General Anesthesia during Endovascular Acute Ischemic Stroke Treatment: A Systematic Review and Meta-Analysis
2014
Toward Understanding Success and Failures in the Use of Selenium for Cancer Prevention
2013
Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis
2016
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
2017
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Insulin Signaling in the Central Nervous System
2005
A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial
2009
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Endovenous thermal ablation for healing venous ulcers and preventing recurrence
2013 StandoutNobel
Multiple Sclerosis
2018 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
The inclusion of reports of randomised trials published in languages other than English in systematic reviews
2003
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation
2004
Treatments for spasticity and pain in multiple sclerosis: a systematic review
2003
Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial
2008
Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials
2010
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure
2004
Essential Role of Pten in Body Size Determination and Pancreatic β-Cell Homeostasis In Vivo
2006 StandoutNobel
Cannabinoids for Medical Use
2015 Standout
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Anti-D administration in pregnancy for preventing Rhesus alloimmunisation
2015
Global cancer statistics, 2012
2015 Standout
Self-monitoring of blood glucose in type 2 diabetes: systematic review
2010
CAR T cell immunotherapy for human cancer
2018 StandoutScience
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure
2003
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Works of Paul Tappenden being referenced
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer
2020
Option appraisal of population-based colorectal cancer screening programmes in England
2006
A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus
2001
Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis
2010
A review and critique of modelling in prioritising and designing screening programmes
2007
A review of the clinical effectiveness of routine antenatal anti‐D prophylaxis for rhesus‐negative women who are pregnant
2004
VALIDATION OF SURROGATE ENDPOINTS IN ADVANCED SOLID TUMORS: SYSTEMATIC REVIEW OF STATISTICAL METHODS, RESULTS, AND IMPLICATIONS FOR POLICY MAKERS
2014
Systematic review of economic evidence for the detection, diagnosis, treatment, and follow-up of colorectal cancer in the United Kingdom
2009
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis
2009
The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales
2007
Supplemental calcium in the chemoprevention of colorectal cancer: A systematic review and meta-analysis
2010
Methodological issues in the economic analysis of cancer treatments
2006
Validation of Surrogate Endpoints in Advanced Solid Tumours: Systematic Review of Statistical Methods, Results, and Implications for Policy Makers
2013
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review
2010
Varenicline in the management of smoking cessation: a single technology appraisal
2009
The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review
2001
The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.
2012
Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
2007
A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative
2003
A Review of Studies Examining the Relationship between Progression-Free Survival and Overall Survival in Advanced or Metastatic Cancer
2012
A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models
2002